Terápiás lehetőségek a gyulladásos bélbetegség állatkísérletes modelljében – összehasonlító vizsgálat [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease]

Introduction: The consequence of inflammatory bowel diseases (IBD) is cytokine-mediated severe local tissue damage. Our aim was to determine the extent of inflammatory response and to influence the morphologic changes during the subacute phase of trinitro-benzene sulfonic acid (TNBS)-induced experim...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kovács Tamás
Varga Gabriella
Érces Dániel
Tőkés Tünde
Tiszlavicz László
Ghyczy Miklós
Vécsei László
Boros Mihály
Kaszaki József
Dokumentumtípus: Cikk
Megjelent: 2012
Sorozat:MAGYAR SEBÉSZET 65 No. 4
Tárgyszavak:
doi:10.1556/MaSeb.65.2012.4.4

mtmt:2078798
Online Access:http://publicatio.bibl.u-szeged.hu/29031
LEADER 02793nab a2200313 i 4500
001 publ29031
005 20231207110245.0
008 231207s2012 hu o 0|| Magyar d
022 |a 0025-0295 
024 7 |a 10.1556/MaSeb.65.2012.4.4  |2 doi 
024 7 |a 2078798  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Magyar 
100 1 |a Kovács Tamás 
245 1 0 |a Terápiás lehetőségek a gyulladásos bélbetegség állatkísérletes modelljében – összehasonlító vizsgálat [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease]  |h [elektronikus dokumentum] /  |c  Kovács Tamás 
260 |c 2012 
300 |a 191-197 
490 0 |a MAGYAR SEBÉSZET  |v 65 No. 4 
520 3 |a Introduction: The consequence of inflammatory bowel diseases (IBD) is cytokine-mediated severe local tissue damage. Our aim was to determine the extent of inflammatory response and to influence the morphologic changes during the subacute phase of trinitro-benzene sulfonic acid (TNBS)-induced experimental colitis by oral phosphatidylcholine (PC) and N-methyl-D-aspartate (NMDA) receptor antagonist kynurenic acid therapy. Methods: Sprague-Dawley rats were randomized to control, untreated colitis (ic TNBS), colitis fed with 2% PC-containing diet (3 days pre-treatment +3 days treatment after TNBS induction), colitis with kynurenic acid treatment (on day 6, n = 7) groups. The colitis was characterized by tissue myeloperoxidase and plasma TNF-alpha levels, the extent of tissue damage, structural changes in microvasculature (FITC-dextran staining) and mucosal injury (acridine orange staining) were determined by in vivo confocal laser scanning endomicroscopy (Optiscan Five1, Australia) and conventional histology (hematoxyilin-eosin staining). Results: Significant elevation in myeloperoxidase and TNF-alpha levels with remarkable damage in epithelial structure was detected in the colitis group. Both treatment regimens significantly decreased the level of inflammatory activation but only PC pretreatment could preserve the number of goblet cells and the epithelial structure. Treatment with kynurenic acid did not alter the morphology changes. Conclusion: Oral PC pretreatment is a promising possibility in the therapy of IBDs through decreasing inflammatory reaction and increasing the number of goblet cells. 
650 4 |a Klinikai orvostan 
700 0 1 |a Varga Gabriella  |e aut 
700 0 1 |a Érces Dániel  |e aut 
700 0 1 |a Tőkés Tünde  |e aut 
700 0 1 |a Tiszlavicz László  |e aut 
700 0 1 |a Ghyczy Miklós  |e aut 
700 0 1 |a Vécsei László  |e aut 
700 0 1 |a Boros Mihály  |e aut 
700 0 1 |a Kaszaki József  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/29031/1/1046-article-p191.pdf  |z Dokumentum-elérés